methotrexate has been researched along with Kawasaki Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Bogatu, B; Kerl, K; Pachlopnik-Schmid, J; Pleimes, M; Theiler, M; Weibel, L; Weins, AB | 1 |
| Furia, FF; Godfrey, E; Mwamanenge, N; Swai, P | 1 |
| Jang, H; Kim, DS; Kim, KY | 1 |
| Chun, JK; Kim, DS; Kim, KH; Lee, TJ | 1 |
| Demirpençe, S; Güven, B; Meşe, T; Oner, T; Tavli, V; Yilmazer, MM | 1 |
| Burgner, D; Kuijpers, TW; Kuipers, IM; Tacke, CE | 1 |
| An, SY; Jang, GC; Kim, DS; Lee, MS | 1 |
1 review(s) available for methotrexate and Kawasaki Disease
| Article | Year |
|---|---|
Management of acute and refractory Kawasaki disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Murine-Derived; Aspirin; Chemotherapy, Adjuvant; Coronary Aneurysm; Cyclosporine; Enzyme Inhibitors; Humans; Immunoglobulins, Intravenous; Methotrexate; Mucocutaneous Lymph Node Syndrome; Rituximab; Tumor Necrosis Factor-alpha | 2012 |
6 other study(ies) available for methotrexate and Kawasaki Disease
| Article | Year |
|---|---|
Febrile ulceronecrotic Mucha-Habermann disease mimicking Kawasaki disease.
Topics: Biopsy; Dermatologic Agents; Diagnosis, Differential; Glucocorticoids; Herpes Simplex; Humans; Infant; Male; Methotrexate; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Pityriasis Lichenoides; Skin; Treatment Outcome | 2020 |
Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania.
Topics: Adolescent; Anemia; Antibodies, Antinuclear; Antirheumatic Agents; Arthralgia; Arthritis, Juvenile; C-Reactive Protein; Child; Child, Preschool; Computed Tomography Angiography; Cyclophosphamide; Dermatomyositis; Echocardiography; Edema; Exanthema; Female; Fever; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Magnetic Resonance Angiography; Male; Methotrexate; Mixed Connective Tissue Disease; Mucocutaneous Lymph Node Syndrome; Prednisolone; Retrospective Studies; Rheumatic Diseases; Takayasu Arteritis; Tanzania; Tertiary Care Centers | 2020 |
Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease.
Topics: C-Reactive Protein; Child; Child, Preschool; Coronary Vessels; Demography; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Infant; Male; Methotrexate; Mucocutaneous Lymph Node Syndrome; Retrospective Studies; Steroids; Treatment Outcome | 2018 |
Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease.
Topics: Child; Child, Preschool; Drug Resistance; Female; Humans; Immunoglobulins, Intravenous; Infant; Male; Methotrexate; Mucocutaneous Lymph Node Syndrome; Treatment Outcome | 2008 |
[Evaluation of unresponsiveness to standard high-dose gamma globulin therapy in Kawasaki disease].
Topics: Age of Onset; Child; Child, Preschool; Coronary Angiography; Coronary Disease; Echocardiography; Female; gamma-Globulins; Humans; Immunoglobulins, Intravenous; Male; Methotrexate; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Treatment Failure; Treatment Outcome | 2010 |
A case of intravenous immunoglobulin-resistant Kawasaki disease treated with methotrexate.
Topics: Child; Humans; Immunoglobulins, Intravenous; Male; Methotrexate; Mucocutaneous Lymph Node Syndrome | 2002 |